| Home > Learning
Center > Chemotherapy Quotes
Chemotherapy Quotes
Article Description:
"Two to 4% of cancers respond to chemotherapy….The bottom line is for a few kinds of cancer chemo is a life extending procedure---Hodgkin's disease, Acute Lymphocytic Leukemia (ALL), Testicular cancer, and Choriocarcinoma."
Date of Publication:4/5/2003
Chemotherapy quotes
"Two to 4% of cancers respond to chemotherapy….The bottom line is for a few
kinds of cancer chemo is a life extending procedure---Hodgkin's disease, Acute
Lymphocytic Leukemia (ALL), Testicular cancer, and Choriocarcinoma."----Ralph
Moss, Ph.D. 1995 Author of Questioning Chemotherapy.
"NCI now actually anticipates further increases, and not
decreases, in cancer mortality rates, from 171/100,000 in 1984 to 175/100,000 by the year
2000!"--Samuel Epstein.
"A study of over 10,000 patients shows clearly that chemo’s supposedly strong
track record with Hodgkin’s disease (lymphoma) is actually a lie. Patients who
underwent chemo were 14 times more likely to develop leukemia and 6 times more
likely to develop cancers of the bones, joints, and soft tissues than those
patients who did not undergo chemotherapy (NCI Journal 87:10)."—John Diamond
Children who are successfully treated for Hodgkin's disease are 18 times more
likely later to develop secondary malignant tumours. Girls face a 35 per cent
chance of developing breast cancer by the time they are 40----which is 75 times
greater than the average. The risk of leukemia increased markedly four years
after the ending of successful treatment, and reached a plateau after 14 years,
but the risk of developing solid tumours remained high and approached 30 per
cent at 30 years (New Eng J Med, March 21, 1996)
"Success of most chemotherapy is appalling…There is no scientific evidence
for its ability to extend in any appreciable way the lives of patients suffering
from the most common organic cancer…chemotherapy for malignancies too advanced
for surgery which accounts for 80% of all cancers is a scientific
wasteland."---Dr Ulrich Abel. 1990
The New England Journal
of Medicine Reports— War on Cancer Is a Failure:
Despite $30 billion spent on research and treatments since 1970, cancer remains
"undefeated," with a death rate not lower but 6% higher in 1997 than 1970,
stated John C. Bailar III, M.D., Ph.D., and Heather L. Gornik, M.H.S., both of
the Department of Health Studies at the University of Chicago in Illinois. "The
war against cancer is far from over," stated Dr. Bailar. "The effect of new
treatments for cancer on mortality has been largely disappointing."
"My studies have proved conclusively that untreated cancer victims live up to
four times longer than treated individuals. If one has cancer and opts to do
nothing at all, he will live longer and feel better than if he undergoes
radiation, chemotherapy or surgery, other than when used in immediate
life-threatening situations."---Prof Jones. (1956 Transactions of the N.Y.
Academy of Medical Sciences, vol 6. There is a fifty page article by Hardin
Jones of National Cancer Institute of Bethesda, Maryland. He surveyed global
cancer of all types and compared the untreated and the treated, to conclude
that
the untreated outlives the treated, both in terms of quality and in
terms of quantity. Secondly he said, "Cancer does not cure". Third he said "There is a
physiological mechanism which finishes off an individual".)
"With some cancers, notably liver, lung, pancreas, bone and advanced breast,
our 5 year survival from traditional therapy alone is virtually the same as it
was 30 years ago."---P Quillin, Ph.D.
"1.7% increase in terms of success rate a year, its nothing. By the time we
get to the 24 century we might have effective treatments, Star Trek will be long
gone by that time." Ralph Moss.
"….chemotherapy’s success record is dismal. It can achieve remissions in
about 7% of all human cancers; for an additional 15% of cases, survival can be
"prolonged" beyond the point at which death would be expected without treatment.
This type of survival is not the same as a cure or even restored quality of
life."—John Diamond, M.D.
"Keep in mind that the 5 year mark is still used as the official guideline
for "cure" by mainstream oncologists. Statistically, the 5 year cure makes
chemotherapy look good for certain kinds of cancer, but when you follow cancer
patients beyond 5 years, the reality often shifts in a dramatic way."—Diamond.
Studies show that women taking tamoxifen after surviving breast cancer then
have a high propensity to develop endometrial cancer. The NCI and Zeneca
Pharmaceuticals, which makes the drug, aggressively lobbied State of California
regulators to keep them from adding tamoxifen to their list of carcinogens.
Zeneca is one of the sponsors of Breast Cancer Awareness Month.
"Most cancer patients in this country die of chemotherapy…Chemotherapy does
not eliminate breast, colon or lung cancers. This fact has been documented for
over a decade. Yet doctors still use chemotherapy for these tumours…Women with
breast cancer are likely to die faster with chemo than without it."—Alan Levin,
M.D.
According to the Cancer
Statistics for 1995, published by the ACS in their small journal (2), the
5-year survival rate has improved from
50%-56% for whites
and 39%-40% for blacks from 1974/1976 - 1983/1990. However, the data is taken
from FIVE of the states with the lowest death rates AND the smallest
populations! NONE of the 10 states with the highest death rates AND comprising
34% of the Total U.S. Cancer Deaths, were included in the data! Also, in
prior
years, the Composite (Ave.) 5-year survival rate for ALL Cancers Combined was
computed and published. This Ave. 5-year survival crept upward to 50%,
in the
early nineties. It now stands around 51-52%, due primarily to the improvement
of 11% survival for Colon and 13% increased survival for Prostate. It gets
worse.
The ACS boasts of "statistically significant" results when Uterine Ca survival
drops from 89%/60%-85%/55% (W/B)?? Also, Pancreas Ca is 3-3 (W) and Laryngeal
Ca
survival drops from 59%-53% (B) while Cervical Ca drops from 63%-56% (B). Liver
Ca improves from 4%-7%. I wonder how many Pancreatic and Hepatic Ca patients
cheered these dramatic results? Ovarian Ca = 36%/40% - 42%/38% (W/B) and Breast
Ca = 75%/63% - 82%/66% (W/B). In 16 years the Breast Ca rate improved 3-7%,
while Uterine Ca decreased 4-5%. Aren't these marvelous results that the Cancer
Establishment should boast about??----RD Hodgell, M.D.
"The five year cancer survival statistics of the American
Cancer Society are very misleading. They now count things that are not cancer,
and, because we are able to diagnose at an earlier stage of the disease,
patients falsely appear to live longer. Our whole cancer research in the past 20
years has been a failure. More people over 30 are dying from cancer than ever
before…More women with mild or benign diseases are being included in statistics
and reported as being "cured". When government officials point to survival
figures and say they are winning the war against cancer they are using those
survival rates improperly."---Dr J. Bailer, New England Journal of Medicine (Dr
Bailer’s answer to questions put by Neal Barnard MD of the Physicians Committee
For Responsible Medicine and published in PCRM Update, sept/oct 1990.
"I look upon cancer in the same way that I look upon heart disease,
arthritis, high blood pressure, or even obesity, for that matter, in that by
dramatically strengthening the body's immune system through diet, nutritional
supplements, and exercise, the body can rid itself of the cancer, just as it
does in other degenerative diseases. Consequently, I wouldn't have chemotherapy
and radiation because I'm not interested in therapies that cripple the immune
system, and, in my opinion, virtually ensure failure for the majority of cancer
patients."---Dr Julian Whitaker, M.D.
"Finding a cure for cancer is absolutely contraindicated by the profits of
the cancer industry’s chemotherapy, radiation, and surgery cash trough."—Dr
Diamond, M.D.
"We have a multi-billion dollar industry that is killing people, right and
left, just for financial gain. Their idea of research is to see whether two
doses of this poison is better than three doses of that poison."—Glen Warner,
M.D. oncologist.
John Robbins:
- "Percentage
of cancer patients whose lives are predictably saved by
chemotherapy - 3%
- Conclusive evidence (majority of cancers) that chemotherapy has any
positive influcence on survival or quality of life - none.
- Percentage
of oncologists who said if they had cancer they would not participate
in chemotherapy trials
due to its "ineffectiveness and its
unacceptable toxicity" - 75%
- Percentage of people with cancer in the U.S. who receive chemotherapy -
75%.
- Company that accounts for nearly half of the chemotherapy sales in the
world - Bristol-Meyers Squibb.
- Chairman of the board of Bristol-Meyers - Richard L. Gelb.
- Mr. Gelb's other job: vice chairman, board of overseers, board of
managers, Memorial Sloan-Kettering Cancer Center, World's largest private
cancer treatment and research center.
- Chairman, Memorial Sloan-Kettering's board of overseers, board of managers
- John S. Reed.
- Reed's other job - director, Philip Morris (tobacco company).
- Director, Ivax, Inc., a prominent chemotherapy company - Samuel Broder.
- Broder's
other job (until 1995) - executive director, National Cancer
Institute."from Reclaiming Our Health:
Exploding the Medical Myth and Embracing the Source of True Healing
by John Robbins.
"If you can shrink the tumour 50% or more for 28 days you have got the FDA's
definition of an active drug. That is called a response rate, so you have a
response..(but) when you look to see if there is any life prolongation from
taking this treatment what you find is all kinds of hocus pocus and song and
dance about the disease free survival, and this and that. In the end there is no
proof that chemotherapy in the vast majority of cases actually extends life, and
this is the GREAT LIE about chemotherapy, that somehow there is a correlation
between shrinking a tumour and extending the life of the patient."---Ralph
Moss
"The majority of publications equate the effect of chemotherapy with (tumour)
response, irrespective of survival. Many oncologists take it for granted that
response to therapy prolongs survival, an opinion which is based on a fallacy
and which is not supported by clinical studies. To date there is no clear
evidence that the treated patients, as a whole, benefit from chemotherapy as to
their quality of life."---Abel.1990.
"For the majority of the cancers we examined, the actual improvements (in
survival) have been small or have been overestimated by the published rates...It
is difficult to find that there has been much progress...(For breast cancer),
there is a slight improvement...(which) is considerably less than
reported."---General Accounting Office
"As a chemist trained to interpret data, it is incromprehensible to me that
physicians can ignore the clear evidence that chemotherapy does much, much more
harm than good."---Alan Nixon, Ph.D., Past President, American Chemical Society.
"He said, "I'm giving cancer patients over here at this major cancer clinic
drugs that are killing them, and I can't stop it because they say the protocol's
what's important." And I say, "But the patient's not doing well." They say, "The
protocol's what's important, not the patient." And he said, "You can't believe
what goes on in the name of medicine and science in this country." --Gary Null
The Politics of Cancer---Epstein
That
in spite of over $20 billion expenditures since the "War against Cancer" was
launched by President Nixon in 1971, there has been little if any
significant improvement in treatment
and survival rates for most common cancers,
in spite of contrary misleading hype by the cancer establishment---the National
Cancer Institute (NCI) and American Cancer Society (ACS).
That the cancer establishment remains myopically fixated on damage control
_diagnosis and treatment _ and basic genetic research, with, not always benign,
indifference to cancer prevention. Meanwhile, the incidence of cancer, including
nonsmoking cancers, has escalated to epidemic proportions with lifetime cancer
risks now approaching 50%.
That the NCI has a long track record of budgetary shell games in efforts to
mislead Congress and the public with its claim that it allocates substantial
resources to cancer prevention. Over the last year, the NCI has made a series of
widely divergent claims, ranging from $480 million to $1 billion, for its
prevention budget while realistic estimates are well under $100 million.
That the NCI allocates less than 1% of its budget to research on occupational
cancer _ the most avoidable of all cancers _ which accounts for well over 10% of
all adult cancer deaths, besides being a major cause of childhood cancer.
That
cancer establishment policies, particularly those of the ACS, are
strongly influenced by pervasive conflicts
of interest with the cancer drug and
other industries. As admitted by former NCI director Samuel Broder, the NCI
has become "what amounts to a governmental pharmaceutical company."
That
the MD Anderson Comprehensive Cancer Center was sued in August,
1998 for making unsubstantiated claims
that it cures "well over 50% of people with
cancer."
That the NCI, with enthusiastic support from the ACS _ the tail that wags the
NCI dog _ has effectively blocked funding for research and clinical trials on
promising non-toxic alternative cancer drugs for decades, in favor of highly
toxic and largely ineffective patented drugs developed by the multibillion
dollar global cancer drug industry. Additionally, the cancer establishment has
systematically harassed the proponents of non-toxic alternative cancer drugs.
That,
as reported in The Chronicle of Philanthropy, the ACS is "more
interested in accumulating wealth than saving lives." Furthermore, it is the
only known "charity" that makes contributions to political parties.
That the NCI and ACS have embarked on unethical trials with two hormonal
drugs, tamoxifen and Evista, in ill-conceived attempts to prevent breast cancer
in healthy women while suppressing evidence that these drugs are known to cause
liver and ovarian cancer, respectively, and in spite of the short-term lethal
complications of tamoxifen. The establishment also proposes further
chemoprevention trials this fall on tamoxifen, and also Evista, in spite of two
published long-term European studies on the ineffectiveness of tamoxifen. This
represents medical malpractice verging on the criminal.
That the ACS and NCI have failed to provide Congress and regulatory agencies
with available scientific information on a wide range of unwitting exposures to
avoidable carcinogens in air, water, the workplace, and consumer products _food,
cosmetics and toiletries, and household products. As a result, corrective
legislative and regulatory action have not been taken.
That
the cancer establishment has also failed to provide the public,
particularly African American and underprivileged ethnic groups
with their
disproportionately higher cancer incidence rates, with information on avoidable
carcinogenic exposures, thus depriving them of their right-to-know
and
effectively preventing them from taking action to protect themselves _ a
flagrant denial of environmental justice.
>> Return
to Articles List
|